Showing results (11-20 of 43) with videos related to
Sort By:
Pageof 5
The Journal of Head Trauma Rehabilitation|February 1, 2018
Investigating the Model of Community-Based Case Management in the New South Wales Brain Injury Rehabilitation Program: A Prospective Multicenter StudyGrahame Simpson, Virginia Mitsch, Margaret Doyle, et al.JPGN Reports|May 19, 2023
Association of Fecal Calprotectin With Endoscopic and Histologic Activity in Pediatric Inflammatory Bowel DiseaseErin Crawford, Catherine Gestrich, Sindhoosha Malay, et al.Journal of Cancer|August 1, 2013
Low Frequency of the ERG Oncogene Alterations in Prostate Cancer Patients from IndiaSudhir Rawal, Denise Young, Molly Williams, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2002
Maspin expression profile in human prostate cancer (CaP) and in vitro induction of Maspin expression by androgen ablationZhiqiang Zou, Wei Zhang, Denise Young, et al.Anticancer Research|January 30, 2003
p63 expression profile in normal and malignant prostate epithelial cellsLeland D Davis, Wei Zhang, Axel Merseburger, et al.Frontiers in Public Health|July 14, 2026
Perinatal wellbeing through restoring healthy family systems in a nêhiyaw (Plains Cree) community: a mixed methods studyRichard T Oster, Luwana Listener, Denise Young, et al.BMC Health Services Research|September 12, 2024
Ohpikihâwasowin (grounding and guiding on the path to be a healthy parent): virtual adaptation of an Elders mentoring program to support maternal and child wellbeing during the COVID-19 pandemicDenise Young, Luwana Listener, Maria Fernanda Torres Ruiz, et al.Molecular and Clinical Oncology|October 4, 2014
Predominance of ERG-negative high-grade prostate cancers in African American menJames Farrell, Denise Young, Yongmei Chen, et al.Oncotarget|April 29, 2020
Association of germline genetic variants with <i>TMPRSS2-ERG</i> fusion status in prostate cancerIndu Kohaar, Qiyuan Li, Yongmei Chen, et al.The Oncologist|November 19, 2020
Molecular Profiling of Exceptional Responders to Cancer TherapyMarijo Bilusic, Daniel Girardi, Yan Zhou, et al.Pageof 5